Agilent Technologies (NYSE:A) Releases FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 5.540-5.610 for the period, compared to the consensus earnings per share estimate of 5.570. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its Q2 2025 guidance to 1.250-1.280 EPS.

Agilent Technologies Price Performance

Shares of NYSE:A traded down $0.39 on Friday, reaching $126.70. 612,594 shares of the company were exchanged, compared to its average volume of 1,693,555. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. Agilent Technologies has a 1-year low of $124.16 and a 1-year high of $155.35. The company has a 50-day moving average of $140.78 and a 200-day moving average of $139.20. The firm has a market cap of $36.14 billion, a price-to-earnings ratio of 29.12, a price-to-earnings-growth ratio of 3.64 and a beta of 1.07.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.58%. Equities analysts forecast that Agilent Technologies will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.78%. Agilent Technologies’s dividend payout ratio is presently 22.76%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on A. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Robert W. Baird dropped their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Citigroup upped their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $146.15.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.